Drug Trial Aims at Traumatic Brain Injury Treatment [Infographic]
Over 3.5 million people suffer traumatic brain injuries every year. That is more than breast cancer, HIV, and multiple sclerosis combined (1.6 million), according to the most recent data from the U.S. Centers for Disease Control and Prevention (CDC). Despite being one of the most common injuries around the world, there is currently no acute treatment for the injury or its symptoms.
The condition is complex and can affect numerous areas of the body, which makes treatment difficult. The problems are made worse by the fact that nearly every brain injury is unique.
However, there is a trial underway hoping to treat TBI and its complex symptoms using the hormone progesterone. Most know of progesterone as a pregnancy hormone, but as the Journey Sentinel reports, progesterone is made in both male and female central nervous systems and offers neurological protection.
The clinical studies which showed that progesterone assists neurological protection and healing inspired SyNAPSe(R), a global, Phase III clincal trial to study the effectiveness of progesterone as a treatment for severe traumatic brain injury. To help educate the public about the trial, SyNAPSe has released information on their website as well as a helpful infographic shared below.